In response to a recent Facebook post warning from using lidocaine solution to treat infants and children with teething pain based on a safety communication published in 2014 by the US Food and Drug Administration (FDA), the Egyptian Pharmaceutical Vigilance Center (EPVC) emphasizes that this warning is concerned with prescription oral viscous lidocaine 2 percent solution These products are not approved to treat teething pain, and use in infants and young children can cause serious harm, including death.

There are other preparations registered in Egypt containing lidocaine, but this warning does not apply on them. Dentinox teething gel contains lidocaine with concentration of 0.33% only. It is still registered and marketed in the UK till date for use to relieve the pain of baby's teething and soothes the gums.

Other prepatarion "Micoban", it contains lidocaine with a concentration of 0.66% (less than 2%) and is used as curative prophylactic therapy for oral candidiasis, and is not used to treat teething pain in Children.